204 related articles for article (PubMed ID: 14607251)
21. Role of protease-activated receptors in the vascular system.
Hirano K; Kanaide H
J Atheroscler Thromb; 2003; 10(4):211-25. PubMed ID: 14566084
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiological actions of protease activated receptors (PARs).
Pandya NM; Jain SM; Santani DD
Pharmazie; 2007 Mar; 62(3):163-9. PubMed ID: 17416190
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms regulating Proteinase-Activated Receptors (PARs).
Chandrabalan A; Ramachandran R
FEBS J; 2021 Apr; 288(8):2697-2726. PubMed ID: 33742547
[TBL] [Abstract][Full Text] [Related]
24. Protease signaling to G protein-coupled receptors: implications for inflammation and pain.
Dale C; Vergnolle N
J Recept Signal Transduct Res; 2008; 28(1-2):29-37. PubMed ID: 18437628
[TBL] [Abstract][Full Text] [Related]
25. Regulation of endothelial prostacyclin synthesis by protease-activated receptors: mechanisms and significance.
Wheeler-Jones CP
Pharmacol Rep; 2008; 60(1):109-18. PubMed ID: 18276992
[TBL] [Abstract][Full Text] [Related]
26. Blocking receptors on the inside: pepducin-based intervention of PAR signaling and thrombosis.
Kuliopulos A; Covic L
Life Sci; 2003 Dec; 74(2-3):255-62. PubMed ID: 14607253
[TBL] [Abstract][Full Text] [Related]
27. Protease activated receptors in cardiovascular function and disease.
Barnes JA; Singh S; Gomes AV
Mol Cell Biochem; 2004 Aug; 263(1-2):227-39. PubMed ID: 15524183
[TBL] [Abstract][Full Text] [Related]
28. Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.
Gieseler F; Ungefroren H; Settmacher U; Hollenberg MD; Kaufmann R
Cell Commun Signal; 2013 Nov; 11():86. PubMed ID: 24215724
[TBL] [Abstract][Full Text] [Related]
29. Proteinase-activated receptors (PARs) as targets for antiplatelet therapy.
Cunningham M; McIntosh K; Bushell T; Sloan G; Plevin R
Biochem Soc Trans; 2016 Apr; 44(2):606-12. PubMed ID: 27068977
[TBL] [Abstract][Full Text] [Related]
30. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
31. Structure, function and pathophysiology of protease activated receptors.
Adams MN; Ramachandran R; Yau MK; Suen JY; Fairlie DP; Hollenberg MD; Hooper JD
Pharmacol Ther; 2011 Jun; 130(3):248-82. PubMed ID: 21277892
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptors: contribution to physiology and disease.
Ossovskaya VS; Bunnett NW
Physiol Rev; 2004 Apr; 84(2):579-621. PubMed ID: 15044683
[TBL] [Abstract][Full Text] [Related]
33. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
[TBL] [Abstract][Full Text] [Related]
34. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
[TBL] [Abstract][Full Text] [Related]
35. Protease signaling in tumor progression.
Camerer E
Thromb Res; 2007; 120 Suppl 2():S75-81. PubMed ID: 18023718
[TBL] [Abstract][Full Text] [Related]
36. The role of proteases in pain.
McDougall JJ; Muley MM
Handb Exp Pharmacol; 2015; 227():239-60. PubMed ID: 25846622
[TBL] [Abstract][Full Text] [Related]
37. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.
Pawlinski R; Mackman N
Crit Care Med; 2004 May; 32(5 Suppl):S293-7. PubMed ID: 15118533
[TBL] [Abstract][Full Text] [Related]
38. [Development of agonists/antagonists for protease-activated receptors (PARs) and the possible therapeutic application to gastrointestinal diseases].
Sekiguchi F
Yakugaku Zasshi; 2005 Jun; 125(6):491-8. PubMed ID: 15930817
[TBL] [Abstract][Full Text] [Related]
39. Proteinase-activated receptors.
Macfarlane SR; Seatter MJ; Kanke T; Hunter GD; Plevin R
Pharmacol Rev; 2001 Jun; 53(2):245-82. PubMed ID: 11356985
[TBL] [Abstract][Full Text] [Related]
40. Protease Activated Receptors and Arthritis.
Lucena F; McDougall JJ
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
